Literature DB >> 1874930

Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.

M E Solal1, J L Sebert, B Boudailliez, A Marie, P Moriniere, J Gueris, R Bouillon, A Fournier.   

Abstract

The predictive value of three different RIAs of PTH for the diagnosis of the histological type of bone disease has been compared in 24 asymptomatic patients on chronic hemodialysis who had never been exposed to aluminum intoxication and who agreed to have a bone biopsy after double tetracycline labeling. The serum concentrations of PTH were measured using a two-site immunoradiometric assay for intact PTH(1-84) and region specific assays directed against the C-terminal (53-84) fragment or the midregion (44-68) of the molecule. The bone histomorphometric analysis showed that six patients had nonaluminic adynamic bone disease with low bone formation rate (BFR), eight had mild hyperparathyroidism characterized by increased bone resorption and normal BFR, nine had severe hyperparathyroidism with increased BFR, and only one had true osteomalacia with increased osteoid seam thickness. All PTH assays correlated with the various parameters of bone resorption and bone formation and were able to differentiate the histological type of bone disease only when groups of patients were considered. For classifying individual patients into severe hyperparathyroidism and adynamic bone disease groups, the intact PTH assay had the best predictive value with a sensitivity of 100% and a specificity of at least 70%. A nonaluminic adynamic bone disease was observed in more than 50% of the patients who had normal intact PTH levels (6/11). It is concluded that the intact PTH measurement is superior to C-terminal and midregion assays for the prediction of the histological type of bone disease in hemodialyzed patients and should be of considerable value to adapt their treatment in order to avoid the emergence of both severe hyperparathyroidism and adynamic bone disease. In the absence of aluminum intoxication it seems that maintaining intact PTH concentrations 1 to 1.5 times the upper limit of normal would correspond to the best bone histology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874930     DOI: 10.1210/jcem-73-3-516

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Effect of haemodialysis on markers of bone turnover in children.

Authors:  Simon Waller; Deborah Ridout; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

Review 2.  Are new vitamin D analogues in renal bone disease superior to calcitriol?

Authors:  Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714

3.  Calcium and phosphate balance in adolescents on home nocturnal haemodialysis.

Authors:  Daljit K Hothi; Elizabeth Harvey; Elizabeth Piva; Laura Keating; Donna Secker; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2006-04-01       Impact factor: 3.714

Review 4.  New PTH assays and renal osteodystrophy.

Authors:  Isidro B Salusky; Harald Jüppner
Journal:  Pediatr Nephrol       Date:  2004-05-15       Impact factor: 3.714

5.  Parathyroid subcutaneous pre-sternal transplantation after parathyroidectomy for renal hyperparathyroidism. Long-term graft function.

Authors:  Miguel Echenique-Elizondo; José Antonio Amondarain; Fernando Vidaur; Carmen Olalla; Fernando Aribe; Adolfo Garrido; José Molina; Maria Teresa Rodrigo
Journal:  World J Surg       Date:  2007-05-22       Impact factor: 3.352

6.  Intact parathyroid hormone levels in renal insufficiency.

Authors:  V T Fajtova; M H Sayegh; N Hickey; P Aliabadi; J M Lazarus; M S LeBoff
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

Review 7.  Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia.

Authors:  T B Drüeke
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

8.  Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders.

Authors:  César Truyts; Melani Custodio; Roberto Pecoit-Filho; Thyago Proenca de Moraes; Vanda Jorgetti
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

9.  Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.

Authors:  Cai Mei Zheng; Chia Chao Wu; Chien Lin Lu; Yi Chou Hou; Mai Szu Wu; Yung Ho Hsu; Remy Chen; Tian Jong Chang; Jia Fwu Shyu; Yuh Feng Lin; Kuo Cheng Lu
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.